Sysmex (OTCMKTS:SSMXY) Announces FY 2026 Earnings Guidance

Sysmex (OTCMKTS:SSMXY – Get Free Report) updated its FY 2026 earnings guidance on Tuesday morning. The company provided earnings per share (EPS) guidance of 0.415-0.415 for the period, compared to the consensus earnings per share estimate of 0.440. The company issued revenue guidance of $3.5 billion, compared to the consensus revenue estimate of $3.1 billion.

Sysmex Trading Up 3.4%

Shares of Sysmex stock opened at $13.55 on Tuesday. The stock has a market cap of $8.24 billion, a P/E ratio of 32.26 and a beta of 1.20. The company has a quick ratio of 2.53, a current ratio of 3.40 and a debt-to-equity ratio of 0.23. Sysmex has a 12-month low of $8.01 and a 12-month high of $13.56. The business’s 50 day moving average is $12.01 and its 200-day moving average is $10.03.

Sysmex (OTCMKTS:SSMXY – Get Free Report) last released its earnings results on Tuesday, November 10th. The company reported $0.10 earnings per share for the quarter, meeting the consensus estimate of $0.10. Sysmex had a net margin of 7.62% and a return on equity of 8.01%. Sysmex has set its FY 2026 guidance at 0.415-0.415 EPS. Equities research analysts predict that Sysmex will post 0.41 earnings per share for the current fiscal year.

Wall Street Analyst Weigh In

Separately, Zacks Research raised shares of Sysmex from a “strong sell” rating to a “hold” rating in a research report on Tuesday, August 18th. Two analysts have rated the stock with a Hold rating. According to MarketBeat, the stock currently has an average rating of “Hold”.

View Our Latest Stock Analysis on Sysmex

Sysmex Company Profile

(Get Free Report)

Sysmex Corporation is a Japan-based healthcare technology company that develops, manufactures and sells diagnostic testing instruments, reagents and related services. Its products are used by hospitals, clinical laboratories and other healthcare providers to analyze patient samples and support medical diagnosis.

The company is best known for its hematology testing systems and also offers products for hemostasis, urinalysis, clinical chemistry and immunochemistry, as well as laboratory information systems and support services.

Read More

Receive News & Ratings for Sysmex Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sysmex and related companies with MarketBeat.com's FREE daily email newsletter.